Falk Transformational Research Award
The Falk Transformational Research Award supports prior Catalyst Awardees in advancing high-impact translational biomedical research that addresses critical barriers to disease treatment or cure.
Funder: Health Resources in Action
Due Dates (Anticipated): June 2027 (Full application deadline, projected)
Funding Amounts: Up to $1,000,000 total for 2–3 years; max 10% indirect costs included
Summary: Supports Catalyst Awardees in advancing biomedical innovations to overcome scientific or therapeutic barriers and move toward clinical or commercial application.
Key Information: Only prior Catalyst Awardees are eligible; funding is not guaranteed even if benchmarks are met.
Description
The Transformational Research Award, administered by Health Resources in Action on behalf of the Dr. Ralph and Marian Falk Medical Research Trust, is designed to provide 2–3 years of additional funding (up to $1,000,000) to successful Catalyst Award recipients. Its aim is to help bridge the gap between promising translational biomedical research and clinical or commercial development. Projects must target critical scientific or therapeutic roadblocks, with the potential to significantly advance disease treatment or cures. The program emphasizes high-risk, high-reward research that can open new avenues for clinical practice and commercial innovation.
